A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Clinical trial NCT04811560 · RECRUITING
Trial details
- NCT number
- NCT04811560
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2027-02-26
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.